SGO On the Go

Let's do this -- This podcast features patient advocates who share their experiences and offer valuable insights from their journeys as cervical cancer patients and survivors. It is hosted by the Health Equity Subcommittee, a division of the SGO Diversity, Inclusion, and Health Equity (DIHE) Committee.Moderators:Lindsay Kuroki, MD, MSCI, Washington University Physicians, DIHE Health Equity subcommittee ChairNancy Zhou, MD, Rutgers Health - NJMS, DIHE Health Equity subcommittee Member Speakers:Mindy Dunn, Cancer SurvivorLinda Ryan, Cancer Survivor and Patient Advocate Resource Links:Foundation for Women's Cancer (FWC) Cervical Cancer: Your Guide 

This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan ENHERTU®. When to dose adjust and hold or even discontinue Trastuzumab Deruxtecan ENHERTU®. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trastuzumab Deruxtecan ENHERTU®.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:Tracilyn Hall, MDSpeakers:Jennifer MacDonald, PharmD, BCOPKathleen Moore, MDBernard Tawfik, MD 

This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®.  Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trastuzumab Deruxtecan ENHERTU®.  Focusing on dosing, breast scoring, HER2, infusion reactions, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:Tracilyn Hall, MDSpeakers:Jennifer MacDonald, PharmD, BCOPKathleen Moore, MDBernard Tawfik, MD 

This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, checking patient performance status, toxicity, response rates in breast, and line of therapy and treatment option. The multidisciplinary panel will discuss dosing and drug preparation for giving Trastuzumab Deruxtecan ENHERTU®. The session wraps up with some key take home points on Trastuzumab Deruxtecan ENHERTU®.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Member and Moderator:Tracilyn Hall, MDSpeakers:Jennifer MacDonald, PharmD, BCOPKathleen Moore, MDBernard Tawfik, MD 

In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS).Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity. Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many patients may even be candidates for discharge on the day of surgery, so-called same-day discharge (SDD).2023-2024 SGO ERAS Subcommittee Members and Speakers:Lee-may Chen, MD; Subcommittee Lead and ModeratorNawar Latif, MD, MPH, MSCEClarissa Polen-De, MDMichael Shu, MDCollin Sitler, DOBrenna Swift, MD, MASc, MSc, FRCSCDiogo Torres, MD

This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer CenterSarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center Sound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology.

This episode is part 2 of the Immunotherapy Series, which reviews common controversies affecting daily use of immune checkpoint inhibitors (ICIs) in the clinic, such as treatment options for immune related adverse effects beyond corticosteroids, re-challenging after toxicity, use of ICIs in patients with auto-immune conditions, and drug interactions. Moderator:Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/NorthwellSpeakers:Erin Zacholski, PharmD, BCOPAssistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer CenterSarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer Center Sound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology.

Join Dr. Robert Neff as he interviews Drs. Kathleen Moore and Charles Leath, III to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.   Some questions covered during the interview: Since NRG just celebrated its 10-year anniversary during the Summer Meeting, what is the vision for NRG in the next 10 years?What are some of the successes within the past year for the Ovary Subcommittee?What were the most important highlights from the Cervix and Vulvar Subcommittee?Are there opportunities for new members to be involved? This episode was created by Dr. Robert Neff, 2023-2024 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Moore and Leath, III for your contribution to this episode.Moderator:Robert Neff, MDSpeakers:Kathleen Moore, MDCharles Leath, III, MD Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

Episode three of the Radiation Therapy podcast series discusses radiation techniques and management with regard to locally advanced cervical cancer.  Host/Moderator: Leigh A. Cantrell, MD, MSPHProfessor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - University of VirginiaGuest Speaker:Kara Romano, M.D.Assistant Professor, Department of Radiation Oncology - University of VirginiaSound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology.

Join Dr. Janelle Darby, member of the SGO Clinical Trials Management/Concepts Subcommittee, as she interviews Drs. Evan Graboyes, Jeffrey Hines, and Bhavana Pothuri, addressing continued efforts to improve inclusion of racially and ethnically diverse patients in clinical trials.   Some topics covered during the interview:Barriers to clinical trial enrollment and retention among racially and ethnically diverse patient populations.Role of cooperative research groups in improving access to clinical trials for racially and ethnically diverse patient populations. Discussion of resources and strategies to improve recruitment and retention of racially and ethnically diverse patient populations in clinical trials.2023-2024 SGO  Clinical Trials Management/Concepts Subcommittee Member and Moderator:Janelle Pakish Darby, MDSpeakers:Evan Graboyes, MD, MPH, FACSJeffrey Hines, MDBhavana Pothuri, MD, MSSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

This podcast focuses on the surgical site infection reduction bundle as part of the ERAS guidelines that was first published in 2016 and updated in 2019, and the 2020 vulvar and vaginal surgeries ERAS guidelines.Before we dive into the SSI reduction bundle, we want to highlight the importance of patient education and participation in any ERAS protocol. Pre-operative education and psychological preparation is critical. Written information was determined to be superior to verbal in a randomized clinical trial in gynecologic oncology surgery.2023-2024 SGO ERAS Subcommittee Members and Speakers:Lee-may Chen, MD; Subcommittee Lead and ModeratorNawar Latif, MD, MPH, MSCECollin Sitler, DOBrenna Swift, MD, MASc, MSc, FRCSCSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

This is the last of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trabectedin and Doxorubicin. When to dose adjust and hold or even discontinue Trabectedin and Doxorubicin. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trabectedin and Doxorubicin.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOPSpeakers:Sminu Bose, MDJoshua Cohen, MD Claire Marie Mach, PharmD, BCOP    Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

This is the second of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trabectedin and Doxorubicin. Focusing on oral dosing, infusion pump setup, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOPSpeakers:Sminu Bose, MDJoshua Cohen, MD Claire Marie Mach, PharmD, BCOP    Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

This is the first of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. After going over some general information on Trabectedin and Doxorubicin including when to use the drug, checking patient performance status, toxicity, and line of therapy and treatment option for recurring metastasis disease. The multidisciplinary panel will discuss dosing and drug preparation for giving Trabectedin and Doxorubicin. The session wraps up with some key take home points on Trabectedin and Doxorubicin.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOPSpeakers:Sminu Bose, MDJoshua Cohen, MD Claire Marie Mach, PharmD, BCOP    Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

Episode two of the Radiation Therapy podcast series discusses treatment of Oligometastatic disease, re-irradiation and role of palliative radiation, utilization of SBRT, introduction to proton therapy and mitigation of radiation-associated toxicities. Host: Mian M. Shahzad, MD, PhD (Gynecologic Oncologist; H. Lee Moffitt Cancer Center)Guest Speaker: Michael Montejo, MD (Radiation oncologist; H. Lee Moffitt Cancer Center) Sound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology.

This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basic treatment course for patients with high-grade toxicities.Moderator: Karin K. Shih, MDGynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of PharmacyClinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center Sarah Hayward, PharmD, BCOPClinical Pharmacy Specialist, Gynecologic Oncology - OU Health Stephenson Cancer CenterSound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology.

This episode is part 1 of the Radiation Therapy podcast series, which looks to review and address the basic fundamentals of radiation therapy in the gynecologic oncology setting. Host: Mian M. Shahzad, MD PhD (Gynecologic Oncologist; H. Lee Moffitt Cancer Center)Guest Speaker: Michael Montejo, MD (Radiation oncologist; H. Lee Moffitt Cancer Center)  Sound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology.

This is the last of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trametinib. When to dose adjust and hold or even discontinue Trametinib. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trametinib.  2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOPSpeakers:Christina M. Davis, PharmD, BCOPDavid M. Gershenson, MD Rebecca L. Porter, MD, PhD Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

This is the second of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trametinib. Focusing on oral dosing, lab examinations, prophylactic management of skincare reactions, and patient education. The session ends with general take home points on administration and toxicity prevention interventions.2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOPSpeakers:Christina M. Davis, PharmD, BCOPDavid M. Gershenson, MD Rebecca L. Porter, MD, PhD Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

This is the first of the three-part podcast series, Keeping up with the Chemos on Trametinib. After going over some general information on Trametinib including mutation status considerations, baseline lab testing, ocular toxicity, and line of therapy. The multidisciplinary panel will discuss dosing and drug preparation for giving Trametinib. The session wraps up with some key take home points on Trametinib. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJennifer MacDonald, PharmD, BCOP Speakers:Christina M. Davis, PharmD, BCOPDavid M. Gershenson, MD Rebecca L. Porter, MD, PhD Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology. 

The goal of this podcast is to continue our series on key concepts of enhanced recovery after surgery (ERAS®). In September 2022, the SGO Education Committee's ERAS Subcommittee discussed why we do it, and in February 2023, we talked about how we do it. This podcast will complete our trilogy and discuss implementation or looking at how well we do it.Listen to Gregg Nelson, MD, PhD from the University of Calgary discuss ERAS®  implementation including some of the starting points, his experience in his own institution, and key ERAS® lessons learned.  Dr. Nelson is the Deputy Head of the Department of Obstetrics & Gynecology at the Cumming School of Medicine in Calgary, Alberta, Canada and is Chief of Gynecologic Oncology at the Tom Baker Cancer Centre. He is also on the Executive Committee for the international ERAS® Society, and a lead author for the ERAS® Society gynecologic guidelines.2023-2024 ERAS Subcommittee Moderator and Podcast Script Editor:Lee-may Chen, MD2022-2023 Opioid/ERAS Subcommittee Members:Jing-Yi Chern, MD (Moderator)Amanika Kumar, MD (Podcast Script Editor)Podcast Invited Speaker:Gregg Nelson, MD, PhD Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Let's face it, wellness is an ever-evolving concept. Listen in as we celebrate aspects of wellness throughout the SGO community. These are 10–20-minute quarterly snippets to highlight the authentic voices from SGO and beyond. Stay connected and foster community in between SGO meetings. You can find these episodes anywhere you get your SGO on the Go podcasts.To view the SGO Wellness Curriculum, click here. 

Join Dr. Kathryn Mills as she interviews Drs. Jubilee Brown, Ann Klopp, Joyce Lui, and Jyoti Mayadev to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.  Some questions covered during the interview:What are some of the upcoming trials in your disease site that you are most excited about?What advice would you give sites considering opening some of the trials that are available?How can sites get more efficient at screening and enrollment?How can sites increase enrollment of minorities?This episode was created by Dr. Kathryn Mills, a former 2022-2023 member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Jubilee Brown, Ann Klopp, Joyce Lui, and Jyoti Mayadev for your contribution to this episode. Moderator: Kathryn Mills, MDSpeakers:Jubilee Brown, MDAnn Klopp, MD, PhDJoyce Lui, MD, MPHJyoti Mayadev, MD Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This is the first of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. After going over some general information on Mirvetuximab soravtansine including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of APP, Optometrist, and Gynecologic Oncologist educated and prepared for giving Mirvetuximab soravtansine. The session wraps up with some key take home points on Mirvetuximab soravtansine.  2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Julia Canestraro, OD, FAAO Karen Lyle, PA-CKathleen Moore, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This is the second of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of Mirvetuximab soravtansine. Focusing on eye drop prescriptions, home medications, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Julia Canestraro, OD, FAAO Karen Lyle, PA-CKathleen Moore, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This is the last of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Mirvetuximab soravtansine. The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Mirvetuximab soravtansine. Once again, the session ends with take home points for patient monitoring while on Mirvetuximab soravtansine.  2022-2023 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Julia Canestraro, OD, FAAO Karen Lyle, PA-CKathleen Moore, MD Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

The goal of this podcast is to follow-up Key Concepts of enhanced recovery after surgery (ERAS), and This podcast is divided into sections referring to pre-operative, intraoperative, and postoperative considerations. We hope to provide some practical tips on how to develop a successful ERAS program at your institution. We acknowledge that all health systems are a little different. Yet there are some common strategies that can be used in developing collaborations.  In conclusion, how to implement ERAS is to foster communication between various team members, including the patient. We hope this podcast helps to set expectations and promote working in concert to bear the fruit of improved patient outcomes. 2022-2023 SGO Opioid/ERAS Subcommittee Members and Speakers:Lee-may Chen, MD; Subcommittee ChairJing-Yi Chern, MDSharmilee Korets, MDAmanika Kumar, MDAndras Ladanyi, MD, PhDMatthew Wagar, MDErin Hickey Zacholski, PharmDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

 Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Yasmin Lyons, DO and Lisa Rauh, MD discuss the best cervical, vulvar and vaginal cancer when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and joining a study group, visiting the SGO ConnectEd, meeting with your local radiation oncologist to discuss radiation in general and your individual patients managed, knowing landmark trials for prognostic factors (GOG 36), surgery for early-stage vulvar cancer, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices. ABOG and SGO Collaboration during the SGO 2023 Annual Meeting During the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL, representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process, so please keep an eye for the following 2-hour session and three-day roundtable discussions when registering for the upcoming SGO 2023 Annual Meeting and be sure to sign up if interested in participating.                    2-hour ABOG and Stats Session and Three-day Roundtable DiscussionsFriday, March 24, 2023 | 1:00 – 4:00 pm | Special Interest Session III: Resident, Fellow, Candidate SessionBecoming an Expert: Board Certification Support Series: Present the partnership between the SGO Taskforce for Board Certification Support and the American Board of Obstetrics and Gynecology (ABOG) to demystify the logistics of the gynecologic oncology subspecialty certifying exam and the assessment and scoring process. Overview with ABOGStatistics Overview Three-day SGO Taskforce for Board Certification Support Roundtable Discussions – Part 1-3 | (7:15-8:15am)Target Audience: Candidates Taking Boards in April 2023The three-day roundtable will include discussions from taskforce facilitators covering hypothetical cases and case reviews with candidates that are in line with the sections of the certifying exam.Saturday March 25, 2023:  Ovarian, Peritoneal, Fallopian Tube Cancer (including Chemotherapy)]Sunday March 26, 2023: Uterine Malignancies: Endometrial Cancer, Sarcoma, GTD, otherMonday March 27, 2023: Cervical, Vulvar and Vaginal Cancer and Radiation TherapyResourcesClick here to access SGO ConnectEd to review additional resources on Cervical, Vulvar and Vaginal Cancer.NCCN guidelines, UpToDate, and GYOEDU.ORG.Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Listen to Tracilyn Hall, MD, co-chair of the SGO Taskforce for Board Certification Support, interview Claire Hoppenot, MD and Alexander Melamed, MD discussing the best resources for Uterine Malignancies and GTD Considerations when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding reviewing for the ABOG Gynecology Oncology Certifying Exam.  They will help you reference the ABOG bulletin, resources on the SGO ConnectEd website, as well as relevant studies. In addition to this podcast, the taskforce will offer other informative podcasts focused on high yield topics and best preparation practices. ABOG and SGO Collaboration during the SGO 2023 Annual MeetingDuring the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL, representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process, so please keep an eye for the following 2-hour session and three-day roundtable discussions when registering for the upcoming SGO 2023 Annual Meeting.2-hour ABOG and Stats Session and Three-day Roundtable DiscussionsSpecial Interest Session III: Resident, Fellow, Candidate SessionFriday, March 24, 2023 | 1:00 – 4:00 pmBecoming an Expert: Board Certification Support Series: Present the partnership between the SGO Taskforce for Board Certification Support and the American Board of Obstetrics and Gynecology (ABOG) to demystify the logistics of the gynecologic oncology subspecialty certifying exam and the assessment and scoring process. Overview with ABOG: 1 hour and 30 minutesStatistics Overview: 30 minutes  Three-day SGO Taskforce for Board Certification Support Roundtable Discussions – Part 1-3 | (7:15-8:15am)Target Audience: Candidates Taking Boards in April 2023The three-day roundtable will include discussions from taskforce facilitators covering hypothetical cases and case reviews with candidates that are in line with the sections of the certifying exam.Saturday March 25, 2023:  Ovarian, Peritoneal, Fallopian Tube Cancer (including Chemotherapy)]Sunday March 26, 2023: Uterine Malignancies: Endometrial Cancer, Sarcoma, GTD, otherMonday March 27, 2023: Cervical, Vulvar and Vaginal Cancer and Radiation TherapyResourcesClick here to access SGO ConnectEd to review additional resources on Uterine Malignancies and GTD Considerations.The ABOG Gynecology Oncology Exam bulletin, which has a comprehensive list of possible topics. As for some just general good places to focus as it gets closer to the time of the exam think about NCCN guidelines, UpToDate, and GYOEDU.ORG.Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Join Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, Anna Beavis, MD and Robert Neff, MD discuss the best ovarian cancer resources on surgical considerations, chemotherapy, and genetic testing when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, reviewing case list and grouping your cases to see their similarities/differences, management of toxicities of common targeted therapies for gynecologic cancers, the benefits of joining a study group, attending the SGO Annual Meeting sessions to gain insight, knowing the FDA indications, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices.   ABOG and SGO Collaboration during the SGO 2023 Annual Meeting During the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL, representatives from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process, so please keep an eye for the following 2-hour session and three-day roundtable discussions when registering for the upcoming SGO 2023 Annual Meeting.2-hour ABOG and Stats Session and Three-day Roundtable DiscussionsSpecial Interest Session III: Resident, Fellow, Candidate SessionFriday, March 24, 2023 | 1:00 – 4:00 pm Becoming an Expert: Board Certification Support Series: Present the partnership between the SGO Taskforce for Board Certification Support and the American Board of Obstetrics and Gynecology (ABOG) to demystify the logistics of the gynecologic oncology subspecialty certifying exam and the assessment and scoring process. Overview with ABOG: 1 hour and 30 minutesStatistics Overview: 30 minutes  Three-day SGO Taskforce for Board Certification Support Roundtable Discussions – Part 1-3 | (7:15-8:15am)Target Audience: Candidates Taking Boards in April 2023The three-day roundtable will include discussions from taskforce facilitators covering hypothetical cases and case reviews with candidates that are in line with the sections of the certifying exam.Saturday March 25, 2023:  Ovarian, Peritoneal, Fallopian Tube Cancer (including Chemotherapy)]Sunday March 26, 2023: Uterine Malignancies: Endometrial Cancer, Sarcoma, GTD, otherMonday March 27, 2023: Cervical, Vulvar and Vaginal Cancer and Radiation TherapyResourcesClick here to access SGO ConnectEd to review additional resources on Ovarian Cancer.Review NCCN guidelines, UpToDate, and GYOEDU.ORG.Listen to Key Concepts of Enhanced Recovery After Surgery. ERAS–Why Do We Do It? There are SGO ConnectEd chemo flash cards that are high yield when it comes to toxicities. Special thanks to Drs. Beavis and Neff for your contribution to this episode.Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This is the last of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on Lenvatinib/pembrolizumab.  The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue Lenvatinib/pembrolizumab. Once again, the session ends with take home points for patient monitoring while on Lenvatinib/pembrolizumab.  2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Jennifer MacDonald, Pharm.D, BCOPPamela Soliman, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This is the second of the three-part podcast series, Keeping up with the Chemos on lenvatinib/pembrolizumab. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders and instructions, any consults/monitoring by other specialties, the drug preparation and interventions during administration lenvatinib/pembrolizumab. The session ends with general take home points on administration and patient monitoring period. 2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith Smith, PharmDSpeakers:Dew Hilton, Specialty Pharmacy Technician Jennifer MacDonald, PharmD, BCOPPamela Soliman, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

The first three-part of the Keeping up with the Chemos podcast series focused on tisotumab vedotin, and now this second installment series focuses on lenvatinib/pembrolizumab, which highlights some general information on lenvatinib/pembrolizumab including mechanism of clinical indications for prescribing. The multidisciplinary panel will discuss the aspects of getting a team of nursing, pharmacy, Gynecologist and Ophthalmologist/Optometrist educated and prepared for giving lenvatinib/pembrolizumab. The session wraps up with some key take home points on lenvatinib/pembrolizumab. 2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith Smith, PharmDSpeakers:Jennifer MacDonald, PharmD, BCOPPamela Soliman, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

 Listen to Tracilyn Hall, MD, co-chair of the SGO Taskforce for Board Certification Support, interview Gillian Hsieh, MD and Lavanya H. Palavalli Parsons, MD discussing the best resources for ICU and Perioperative Considerations when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding reviewing your anatomy textbooks and case list to see what co-morbidities your patients have, visiting the SGO ConnectEd for perioperative care topics, knowing what technology and protocol you have at your institution as well as published data, studying bowel injuries, and having tumor board discussions to guide interventions, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices. ABOG and SGO Collaboration During the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL, a representative from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process. Keep an eye for this session opportunity when registering for the upcoming SGO 2023 Annual Meeting and be sure to sign up if interested in participating.  We will also have three roundtable discussions where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases and have an opportunity to discuss some of their own cases. ResourcesClick here to access SGO ConnectEd to review additional resources on ICU and Perioperative Considerations.Listen to Key Concepts of Enhanced Recovery After Surgery. ERAS–Why Do We Do It?There are quick one-page SGO ConnectEd chemo flash cards that are high yield when it comes to toxicities. Read “Principles and Practice of Gynecologic Oncology” and “Gynecologic Oncology Handbook,” which provides some good quick sections on ICU topics.American Society of Clinical Oncology (ASCO) is another organization that has great guidelines that can easily be accessed here.  Special thanks to Drs. Hsieh and Parsons for your contribution to this episode.  Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

The success of an effective clinical research program is essential for developing and maintaining a top-tier clinical research trial team. Join our next podcast on clinical trial management as Dr. Robert Neff interviews Dr. Bradley Monk, Dr. Mark Shahin, and Ashley Douglas, RN, BSN, OCN addressing clinical trials from a community oncology perspective. The discussion includes building a quality clinical trial team, relationship development with industry partners, cooperative group involvement (NRG), the process for initiating clinical research at home institution, and important pitfalls to avoid as a new researcher among other topics.  This episode was moderated by Robert Neff, MD, a member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Special thanks to Bradley Monk, MD, Mark Shahin, MD, and Ashley Douglas, RN, BSN, OCN for your contribution to this episode.Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This episode features recent updates presented at the 2022 European Society for Medical Oncology (ESMO) Congress in Paris, France. SOLO1 study survival data, PAOLA data, and information about novel, early-phase drugs and their practice implications are reviewed by three speaker experts. This is an educational resource produced through collaboration between the Society of Gynecologic Oncology (SGO) and the Cancer Association of Community Cancer Centers (ACCC). 

Join us as Scott Richard, MD, co-chair of the SGO Taskforce for Board Certification Support, interviews Janelle Darby, MD and Kathryn Mills, MD to discuss best resources for radiation oncology when preparing for the ABOG oral board exam. This podcast episode addresses important resources and questions regarding study preparation, radiation prevention strategies, the benefits of joining a study group, reviewing treatment and management of the patients on your case list, knowing the principles of radiation and how it is administered, discussing treatment decisions with your local radiation oncologist, and more. The taskforce will offer six informative podcasts focused on high yield topics and best preparation practices.  ABOG and SGO CollaborationThe American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process during the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL. Keep an eye for this session opportunity when registering for the upcoming SGO 2023 Annual Meeting and be sure to sign up if interested in participating.  We will also have several meetings where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases and have an opportunity to discuss some of their own cases. ResourcesClick here to access SGO ConnectEd to review additional resources on radiation oncology. Radiation Planning Principles for Gynecologic Oncology (part of the Fellow Core Lecture Series) – Hour long lecture from Anuja Jhingran, MD at MD Anderson that reviews radiation fields, IMRT, specific organ dose limits, vaginal brachytherapy delivery to name a few. This is a good overview of radiation basics and treatment for the different disease sites.  SGO Fellows Bootcamp – Another introductory lecture on radiation oncology that was created for new fellows and provides a nice overview.Click here to access the full-text guideline titled, “Radiation Therapy for Cervical Cancer: An ASTRO Clinical Practice Guideline,” which provides recommendations on the use of radiation therapy to treat adult women with cervical cancer. Special thanks to Drs. Darby and Mills for your contribution to this episode.Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Join Dr. Hall, Co-Chair of the SGO Taskforce for Board Certification Support, as she interviews Drs. Mallen and Zeligs, who recently took the ABOG board exam, addressing several different approaches to case list preparation. As part of the taskforce, we have recognized several SGO members who had taken the ABOG board exam have different approaches to their case list preparation, and we wanted to make sure we provide effective resources for all of those candidates coming up this year on what we were able to be successful with our case list. Some questions covered during the interview:What is the timeline for case list creation and submission?How many cases do I need?What cases do I need to include on my list?What about the ABOG approved abbreviations?When should I have the required affidavits signed?The taskforce will also offer other informative podcasts focused on high yield topics and best preparation practices. ABOG and SGO Collaboration During the SGO 2023 Annual Meeting on Women's Cancer in Tampa, FL, a representative from The American Board of Obstetrics & Gynecology (ABOG) will join the SGO Taskforce for Board Certification Support to discuss logistics of the certifying exam as well as the assessment and scoring process. Keep an eye for this session opportunity when registering for the upcoming SGO 2023 Annual Meeting and be sure to sign up if interested in participating.  We will also have several meetings where participants will meet in small groups with a taskforce facilitator to discuss hypothetical cases and have an opportunity to discuss some of their own cases.Special thanks to Drs. Mallen and Zeligs for your contribution to this episode.Moderator: Tracilyn Hall, MD Speakers:Adrianne Mallen, MDKristen Zeligs, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Join Dr. AlHilli as she interviews Dr. Amanda Nickles Fader addressing specific questions of mentorship, conducting clinical trials and rare disease in gynecologic oncology, and having success in clinical trials. Dr. Fader also discussed the SGO BRIDGES Research Initiative, a new, longitudinal clinical trials workshop for early career investigators with the aim of developing the next generation of trialists who will lead investigator-initiated and cooperative group gynecologic cancer clinical studies. It is designed to bridge the gap between translational scientists and clinical trialists in gynecologic oncology by providing formal training for young investigators in clinical trial design, connecting participants with expert mentors, and supporting the development of novel clinical trials.  This episode was created by Mariam AlHilli, MD, a member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Dr. Fader for your contribution to this episode.

This is the last of the three-part podcast series, Keeping up with the Chemos on tisotumab vendotin.  Our multidisciplinary panel will discuss the challenges with patient monitoring while on tisotumab vendotin.  The panel discusses personal clinical experiences and lessons learned.  When to dose adjust and hold or even discontinue tisotumab vendotin. Once again, the session ends with take home points for patient monitoring while on tisotumab vendotin.  Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Judith Smith, PharmDSpeakers:Julia Canestraro, OD, FAAOShannon Westin, MD Erin Hickey Zacholski, PharmDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This is the second of the three-part podcast series, Keeping up with the Chemos on tisotumab vendotin. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of tisotumab vendotin. Focusing in ophthalmology exam prior to each cycle, use of ice packs and eye drop regimen to give prior to infusion and post infusion at home to prevent toxicity. The session ends with general take home points on administration and toxicity prevention interventions. Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Judith Smith, PharmDSpeakers:Julia Canestraro, OD, FAAOShannon Westin, MD Erin Hickey Zacholski, PharmDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This is the first of the three-part podcast series, Keeping up with the Chemos on tisotumab vendotin. After going over some general information on tisotumab vendotin including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of nursing, pharmacy, Gynecologist and Ophthalmologist/Optometrist educated and prepared for giving tisotumab vendotin. The session wraps up with some key take home points on tisotumab vendotin.  Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD  Judith Smith, PharmD Speakers: Julia Canestraro, OD, FAAOShannon Westin, MD Erin Hickey Zacholski, PharmDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

For this latest installment, we have decided to go back to the beginning, and return to key concepts of Enhanced Recovery After Surgery. ERAS–why do we do it? What are the guiding principles? In the next 20 minutes, our working group discussants will address key elements of ERAS and why we do it. Opioid/ERAS Subcommittee Speakers: Lee-may Chen, MDJing-Yi Chern, MDSharmilee Korets, MDAndras Ladanyi, MD, PhDMatthew Wagar, MDErin Hickey Zacholski, PharmD Opioid/ERAS Subcommittee Member and Podcast Script Editor:Amanika Kumar, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Join Dr. Kathryn Mills as she interviews Drs. Allan Covens, Charles Leath, Kathleen Moore, and Matt Powell to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.  This episode was created by Kathryn Mills, MD, a member of the SGO Education Committee's Clinical Trials Management/Concepts Subcommittee. Thanks to Drs. Covens, Leath, Moore, and Powell for your contribution to this episode. Moderator:  Kathryn Mills, MD Speakers:Allan Covens, MD, FRCSC Charles Leath, MD Kathleen Moore, MD Matt Powell, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Sexual problems and dysfunctions are commonly encountered by gynecologic oncologists, dealing both with cancer patients and patients with complex benign conditions. We are offering a two-part series, brought to you by gynecologist Mary Jane Minkin, who discusses these issues. In the first talk, Dr. Minkin talks about the diagnosis of sexual problems routinely encountered by gynecologic oncologists, and in the second talk she discusses therapies for these sexual problems, and advice on referral for patients who need further interventions. Dr. Minkin is the Co-Director of the Sexuality, Intimacy and Menopause Clinic for Cancer Survivors at the Smilow Cancer Center, Yale-New Haven Hospital, and Clinical Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale Medical School.SGO thanks Dr. Mary Jane Minkin for her generosity in providing this education. Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

Sexual problems and dysfunctions are commonly encountered by gynecologic oncologists, dealing both with cancer patients and patients with complex benign conditions. We are offering a two-part series, brought to you by gynecologist Mary Jane Minkin, who discusses these issues. In the first talk, Dr. Minkin talks about the diagnosis of sexual problems routinely encountered by gynecologic oncologists, and in the second talk she discusses therapies for these sexual problems, and advice on referral for patients who need further interventions. Dr. Minkin is the Co-Director of the Sexuality, Intimacy and Menopause Clinic for Cancer Survivors at the Smilow Cancer Center, Yale-New Haven Hospital, and Clinical Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale Medical School.SGO thanks Dr. Mary Jane Minkin for her generosity in providing this education. Sound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.

This podcast focuses on individualized treatment in ovarian cancer.  Case based scenarios are used to help facilitate discussion on targeted therapy for clear cell, low grade serous, and high grade serous ovarian cancers. This is an educational resource produced through collaboration between the Society of Gynecologic Oncology (SGO) and the Cancer Association of Community Cancer Centers (ACCC). 

This episode was written by the SGO Education Committee's Opioid/ERAS Subcommittee:Subcommittee Chair: Lee-may Chen, MDSpecial Guests: Sarah Finlayson, MD; Toure Barksdale, MDSubcommittee Members: Roni Nitecki, MD, Elise Simons, MD, Amanika Kumar, MD, Stuart Winkler, MD, Jeannie Chern, MD, Andras Ladanyi, MDTheme Music: Medical Mask Boogie by Martijn de Boer (NiGiD) (c) copyright 2020 Licensed under a Creative Commons Attribution Noncommercial  (3.0) license. http://dig.ccmixter.org/files/NiGiD/61703 Ft: JavolenusSound engineered and produced by Madi Bivins on behalf of the Society of Gynecologic Oncology.

This episode was written by the SGO Education Committee's Opioid/ERAS Subcommittee:Subcommittee Chair: Lee-may Chen, MDSubcommittee Members: Roni Nitecki, MD, Elise Simons, MD, Amanika Kumar, MD, Stuart Winkler, MD, Jeannie Chern, MD, Andras Ladanyi, MDTheme Music: Medical Mask Boogie by Martijn de Boer (NiGiD) (c) copyright 2020 Licensed under a Creative Commons Attribution Noncommercial  (3.0) license. http://dig.ccmixter.org/files/NiGiD/61703 Ft: JavolenusSound engineered and produced by Madi Bivins on behalf of the Society of Gynecologic Oncology.

This 17-minute Turnover Talk is a follow up to the surgical education webinar "All Things Ostomy: An SGO Surgical Education Webinar" held in September 2021. Brittany Davidson, MD, interviews Christina Fotopoulou, MD, about some of the highlights from her webinar presentation, including pearls of wisdom from her extensive experience. 

Join Dr. Kathryn Mills for an in-depth interview with the principal investigator of the FIRES trial, Dr. Emma Rossi. Dr. Rossi takes us through her tips for getting a surgical trial funded and enrolling and managing patients at multiple clinical sites on a tight budget. This episode was created by the SGO Education Committee's Clinical Trials Subcommittee. Thanks to Dr. Michael Kelley, Kathryn Mills, and Emma Rossi for your contribution to this episode. Subcommittee Chair: Stuart Ferriss, MDSpecial Guest: Emma Rossi, MDSubcommittee Members: Michael Kelley, MD, Kathryn Mills, MD, David Cantu, MD, Marla Scott, MD, Juliet Wolford, MDTheme Music: Medical Mask Boogie by Martijn de Boer (NiGiD) (c) copyright 2020 Licensed under a Creative Commons Attribution Noncommercial  (3.0) license. http://dig.ccmixter.org/files/NiGiD/61703 Ft: JavolenusSound engineered and produced by Madi Bivins on behalf of the Society of Gynecologic Oncology.